Show summary Hide summary
As more people live well into their 70s and beyond, doctors and patients face a sharper question: should routine cholesterol-lowering medicines be continued for older adults who have not had a recent heart attack or stroke? The answer increasingly depends less on age alone and more on health status, goals of care and what the best available evidence actually shows about benefit and harm.
Why this matters now
Population aging and the widespread use of statins mean the decision affects millions. New analyses and guideline discussions over the past few years have pushed the issue into the clinical spotlight: continuing medication may reduce future cardiovascular events in some older adults, but it also brings risks — from drug interactions to side effects — that are more consequential when life expectancy and daily function are limited.
Joey Weslo: latest updates and what to know today
UFC 334: two championship fights at Madison Square Garden promise a blockbuster night

What the evidence says — in plain terms
Randomized trials that originally established the value of statins enrolled relatively few people over 75, so uncertainty remains. Still, several large observational studies and subgroup analyses indicate that:
- For people with established heart disease or stroke (secondary prevention), continuing a statin generally lowers the risk of another event, even at older ages.
- For those without prior cardiovascular events (primary prevention), benefits are smaller and more dependent on overall health, estimated lifespan and baseline risk.
- Evidence is weaker for very frail individuals or those with limited life expectancy, where harms may outweigh potential long-term benefits.
Balancing benefits and harms
Deciding whether to keep a statin requires weighing likely reduction in heart attacks and strokes against possible downsides. Common concerns include muscle aches, risk of diabetes, and interactions with other drugs. For older adults who are taking many medicines (polypharmacy) or who have frequent falls, these harms take on greater significance.

Importantly, fears about memory loss or severe cognitive decline from statins have not been supported by strong evidence; most large studies show no clear link. Still, the small risk of adverse effects — and the time horizon needed to see benefit — must be matched to an individual’s priorities.
How clinicians approach the question
Today, many clinicians use a personalized approach rather than applying an age cutoff. Typical considerations include:
- Whether the statin is being used for secondary prevention (after heart attack or stroke) or for primary prevention.
- Estimated life expectancy and functional status: someone active and healthy at 80 has different calculus than someone with advanced frailty.
- Presence of other illnesses, risk of drug interactions, and patient preferences.
Shared decision-making — a structured conversation about risks, benefits and what matters most to the patient — is now recommended by many geriatric and cardiovascular care groups when the choice is uncertain.
Practical steps patients and families can take
If you or a relative over 70 is on a statin, these actions can clarify whether to continue treatment:
- Bring a current medication list to your clinician and review why the statin was started.
- Ask about your personal risk of heart attack or stroke in the next 5–10 years, and how much the statin is likely to reduce that risk.
- Discuss side effects, interactions with other drugs, and whether a trial off the medication makes sense if concerns exist.
- If stopping is considered, plan for monitoring and revisit the decision periodically, especially if health status changes.
When stopping is reasonable
Clinicians may recommend deprescribing a statin when the burdens of treatment outweigh expected benefit — for example, in people with severe frailty, advanced dementia, or very limited life expectancy. Stopping may also be appropriate if a patient prefers fewer medications after understanding the trade-offs.
Conversely, for an older adult who is independent, has few other illnesses and has already had a heart attack or stroke, continuing a statin is usually recommended because the protective effect is clearer and more immediate.
Ultimately, there is no single rule that fits everyone. For patients, the most useful next step is a frank, practical conversation with a clinician who can translate general evidence into a personalized plan that respects life expectancy, goals and day-to-day priorities.











